SSG
PMC

Summit Securities Group’s PharMerica Corporation PMC Stock Holding History

Summit Securities Group’s Portfolio PMC Stock Details PMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-11,165
Closed -$391K – 375
2015
Q4 		$391K Buy
+11,165
New +$350K 0.13% 120

Other funds holding PMC

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LCP
Lombardia Capital Partners Pasadena, California $110M AUM 13.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Summit Securities Group's PMC Position: Q1 2016 in Review

Summit Securities Group sold out of PharMerica Corporation (PMC) in Q1 2016, closing a stake of 11,165 shares — an estimated $391K sold.

Summit Securities Group first reported a position in PMC in Q4 2015 and held it in 1 quarter. The position peaked at $391K in Q4 2015. 169 funds tracked by Wall St. Rank hold PMC as of Q1 2016.

  • Summit Securities Group reported no remaining PharMerica Corporation position as of Q1 2016 after selling out during the quarter.
  • Summit Securities Group sold 11,165 PharMerica Corporation shares in Q1 2016, an estimated $391K.
  • Summit Securities Group first reported a position in PharMerica Corporation in Q4 2015 and held it in 1 quarter.
  • Summit Securities Group's PharMerica Corporation position peaked at $391K in Q4 2015.
  • 169 funds tracked by Wall St. Rank held PharMerica Corporation as of Q1 2016.

Based on Summit Securities Group's 13F filing for Q1 2016, filed 11 May 2016.